Get the Stockscreener App
2.02
2.55%
0.06
Sera Prognostics Inc stock is traded at $2.02, with a volume of 14,937.
It is up +2.55% in the last 24 hours and down -1.95% over the past month.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
See More
Previous Close:
$1.96
Open:
$1.94
24h Volume:
14,937
Relative Volume:
0.29
Market Cap:
$78.90M
Revenue:
$57,000
Net Income/Loss:
$-32.14M
P/E Ratio:
-3.124
EPS:
-0.6466
Net Cash Flow:
$-27.58M
1W Performance:
+0.00%
1M Performance:
-1.95%
6M Performance:
-22.39%
1Y Performance:
-10.67%
1-Day Range:
$1.94
$2.025
1-Week Range:
$1.89
$2.07
52-Week Range:
$1.56
$3.95
Sera Prognostics Inc Stock (SERA) Company Profile
Name
Sera Prognostics Inc
Sector
Industry
Phone
(801) 990-0520
Address
2749 E. PARLEYS WAY, SALT LAKE CITY
Compare SERA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SERA
Sera Prognostics Inc
|
2.00 | 77.32M | 57,000 | -32.14M | -27.58M | -0.6466 |
ABT
Abbott Laboratories
|
109.69 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.91 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.56 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.48 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.72 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-15-25 | Initiated | Jefferies | Buy |
| Mar-30-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | Oppenheimer | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
Sera Prognostics Inc Stock (SERA) Latest News
Sera Prognostics Inc (NASDAQ: SERA) Share Price, SERA Stock News, SERA Share Price & Updates - kalkine.ca
Sera Prognostics Earnings Call Signals Slow, Strategic Ramp - TipRanks
Sera Prognostics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
William Blair Initiates Sera Prognostics(SERA.US) With Buy Rating - Moomoo
Sera Prognostics Inc (SERA) (Q2 2026) Earnings Call Highlights: Payer Momentum Builds with ... - Yahoo Finance
Sera Prognostics Q2 Earnings Call Highlights - MarketBeat
SERA Looks 10.5% Overvalued on GF Value™ - GuruFocus
Transcript : Sera Prognostics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 - marketscreener.com
Sera Prognostics Q2 2026 loss widens to $9.1 million; Illinois Medicaid mandate - scanx.trade
Earnings call transcript: Sera Prognostics misses Q2 2026 estimates as growth builds - Investing.com
Sera Prognostics (NASDAQ:SERA) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Sera Prognostics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Sera Prognostics Q2 revenue rises on expanded partnerships and Medicaid coverage - TradingView
Sera Prognostics Reports Q2 Revenue of $30000 and $9.1 Million Net Loss - Quiver Quantitative
Sera Prognostics Q2 2026 Earnings: Commercial Progress Has Yet to Produce Material Revenue - TradingKey
Sera Prognostics (SERA) deepens Q2 2026 loss but extends cash runway to 2029 - Stock Titan
Sera Prognostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
SERA PROGNOSTICS REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS - The Herald Journal
Sera Prognostics, Inc. expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Sera Prognostics Inc (SERA) Stock News Today - TradingKey
Sera Prognostics Inc (SERA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sera Prognostics (SERA) Q1 2026 Earnings: EPS Matches Estimates at -$0.17, Stock FlatUpward Estimate Revision - dars.gov.et
Earnings Preview: SERA to Report Financial Results Post-market on August 12 - Moomoo
Earnings To Watch: Sera Prognostics Inc (SERA) Q2 2026 -- GF Val - GuruFocus
Earnings To Watch: Sera Prognostics Inc (SERA) Q2 2026 -- GF Value Sees 22% Downside - Yahoo Finance
SERA Q2'26 Earnings: revenue estimate is 71.38K USD - TradingView
Sera Prognostics (SERA) Expected to Announce Earnings on Wednesday - MarketBeat
Sera Prognostics Inc (SERA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SERA|Sera Prognostics Inc|Price:2.100|Chg%:+0.050 - TradingKey
Sera Prognostics Inc (SERA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Sera Prognostics Inc (SERA) Income Statement - TradingKey
Sera Prognostics Inc (SERA) Cash Flow - TradingKey
SERA|Sera Prognostics Inc|Price:2.050|Chg%:-0.120 - TradingKey
Sera Prognostics Inc (SERA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sera Prognostics Inc. (SERA) Q1 2026 Earnings: In-Line Loss as Pre-Revenue Diagnostics Firm Continues DevelopmentEarnings Acceleration Picks - dars.gov.et
Aberdeen Group plc's Strategic Acquisition of Sera Prognostics I - GuruFocus
Sera Prognostics study shows NICU admission cut in first births By Investing.com - Investing.com Nigeria
abrdn Group holds 7.21% of Sera Prognostics (SERA) stock - Stock Titan
Sera Prognostics Q1 2026 Earnings: EPS Matches Estimates, No Revenue, Stock Jumps 9%Slow Growth Warning - dars.gov.et
Form 4 Sera Prognostics Inc For: 14 July By Investing.com - Investing.com South Africa
Sera Prognostics grants RSUs and options to director | SERA Insider Trading - Stock Titan
Sera Prognostics (SERA) director receives RSU and stock option grants - Stock Titan
Equity grants: Sera Prognostics (SERA) awards RSUs and options - Stock Titan
Sera Prognostics (SERA) grants RSUs and stock options to director Kim Kamdar - Stock Titan
Sera Prognostics (SERA) grants RSUs and options to director - Stock Titan
Sera Prognostics (SERA) awards RSUs and $1.97 stock options to director - Stock Titan
Sera Prognostics (SERA) grants new RSUs and stock options - Stock Titan
Sera Prognostics Inc. (SERA) Edges Lower Amid Consolidation at Key Support ZoneVolatility Smile - dars.gov.et
Sera Prognostics study shows NICU admission cut in first births - Investing.com
Sera Prognostics Inc Stock (SERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sera Prognostics Inc Stock (SERA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Aerts Austin | Chief Financial Officer |
Jun 11 '26 |
Sale |
2.01 |
2,037 |
4,094 |
301,190 |
| Lindgardt Zhenya | Chief Executive Officer |
Jun 11 '26 |
Sale |
2.01 |
6,990 |
14,050 |
865,009 |
| Inglis Tiffany Eul Davis | Chief Medical Officer |
Jun 11 '26 |
Sale |
2.01 |
362 |
728 |
92,075 |
| Jackson Benjamin | General Counsel |
Jun 11 '26 |
Sale |
2.01 |
2,179 |
4,380 |
161,756 |
2.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):